Skip to content

Safety and Efficacy of Aneurysms Treated With Endovascular Devices

Safety and Efficacy of Aneurysms Treated With Endovascular Devices

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07175519
Acronym
SEATED
Enrollment
5000
Registered
2025-09-16
Start date
2025-01-15
Completion date
2035-01-15
Last updated
2025-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Aneurysm, Intracranial Hemorrhages, Stroke

Brief summary

In this project the investigators study the safety and efficacy of the recent endovascular devices used in treatment of brain aneurysms.

Interventions

DEVICEEndovascular treatment of aneurysms

Aneurysm can be treated by endovascular devices using catheters, Treatment modalities can include coils, stents, flow diverters as well as intrasaccular devices

Sponsors

King's College London
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* All patients undergoing endovascular aneurysm treatment.

Exclusion criteria

* All endovascular patients NOT undergoing aneurysm treatment e.g. stents used for stroke treatment; devices and materials used for dAVF, AVM treatments. * Insufficient background data available e.g., to determine size of aneurysm and device.

Design outcomes

Primary

MeasureTime frameDescription
Evaluate predictive factors of aneurysm recurrence after endovascular device embolization (efficacy).Done at short-term (30 days) post procedural and long term (up to 5 years) post proceduralChange of aneurysm from Raymond Roy (RR) classification I into RR II or RR III and correlating this with factors such as smoking.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026